Multicenter trial of a combination probiotic for children with gastroenteritis

New England Journal of Medicine

Volumn 379, Issue 21, 2018, Pages 2015-2026

  Freedman, Stephen B ^a,n   Williamson‑Urquhart, Sarah ^b,g,n   Farion, Ken J ^c,n   Gouin, Serge ^b,d,e,n   Willan, Andrew R ^e,n   Poonai, Naveen ^i,j,n   Hurley, Katrina ^h,k,n   Sherman, Philip M ^f,n   Finkelstein, Yaron ^g,n   Lee, Bonita E ^l,n   Pang, Xiao Li ^m,n   Chui, Linda ^m,n   Schnadower, David ^n,o   Xie, Jianling ^b,n   Gorelick, Marc ^n,p   Schuh, Suzanne ^h,n  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA CHILDREN'S HOSPITAL   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^f Division of Gastroenterology   (Canada)

^g Divisions of Pediatric Emergency Medicine and Clinical Pharmacology and Toxicology   (Canada)

^h Division of Pediatric Emergency Medicine and Research Institute   (Canada)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j LONDON HEALTH SCIENCES CENTRE   (Canada)

^k IWK HEALTH CENTRE   (Canada)

^l Women and Children's Health Research Institute   (Canada)

^m Alberta Public Laboratories and Department of Laboratory Medicine and Pathology   (Canada)

ⁿ UNIVERSITY OF ALBERTA   (Canada)

^o WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEBRILE CONVULSION; FEMALE; GASTROENTERITIS; HEALTH CARE UTILIZATION; HUMAN; INFANT; LACTOBACILLUS HELVETICUS; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING; ACUTE DISEASE; CLINICAL TRIAL; COMPLICATION; PATIENT ACUITY; PRESCHOOL CHILD; TREATMENT FAILURE;

ACUTE DISEASE; CHILD, PRESCHOOL; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; GASTROENTERITIS; HUMANS; INFANT; LACTOBACILLUS HELVETICUS; LACTOBACILLUS RHAMNOSUS; MALE; PATIENT ACUITY; PROBIOTICS; TREATMENT FAILURE; VOMITING;

EID: 85056912892     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1802597     Document Type: Article

References (54)

1. Freedman SB, Steiner MJ, Chan KJ. Oral ondansetron administration in emergency departments to children with gastroenteritis: an economic analysis. PLoS Med 2010;7(19):e1000350
2. Mast TC, DeMuro-Mercon C, Kelly CM, Floyd LE, Walter EB. The impact of rotavirus gastroenteritis on the family. BMC Pediatr 2009;9:11.
3. Yu C. People love probiotics, but do they really help? Washington Post. May 20, 2017.
4. Slattery J, MacFabe DF, Frye RE. The significance of the enteric microbiome on the development of childhood disease: a review of prebiotic and probiotic therapies in disorders of childhood. Clin Med Insights Pediatr 2016;10:91-107.
5. Parker MW, Schaffzin JK, Lo Vecchio A, et al. Rapid adoption of Lactobacillus rhamnosus GG for acute gastroenteritis. Pediatrics 2013;131:Suppl 1:S96-S102.
6. Yi SH, Jernigan JA, McDonald LC. Prevalence of probiotic use among inpatients: a descriptive study of 145 U.S. hospitals. Am J Infect Control 2016;44:548-53.
7. Guarino A, Guandalini S, Lo Vecchio A. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 2015;49: Suppl 1:S37-S45.
8. Kolaček S, Hojsak I, Berni Canani R, et al. Commercial probiotic products: a call for improved quality control: a position paper by the ESPGHAN working group for probiotics and prebiotics. J Pediatr Gastroenterol Nutr 2017;65:117-24.
9. Johnston BC, Shamseer L, da Costa BR, Tsuyuki RT, Vohra S. Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review. Pediatrics 2010;126(1):e222-e231.
10. Sénécal M, Brisson M, Lebel MH, et al. Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): a prospective community-based study. Can J Infect Dis Med Microbiol 2008;19:397-404.
11. Le Saux N, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW. Substantial morbidity for hospitalized children with community-acquired rotavirus infections: 2005-2007 IMPACT surveillance in Canadian hospitals. Pediatr Infect Dis J 2010; 29:879-82.
12. Nixon AF, Cunningham SJ, Cohen HW, Crain EF. The effect of Lactobacillus GG on acute diarrheal illness in the pediatric emergency department. Pediatr Emerg Care 2012;28:1048-51.
13. Freedman SB, Eltorky M, Gorelick M. Evaluation of a gastroenteritis severity score for use in outpatient settings. Pediatrics 2010;125(6):e1278-e1285.
14. Schnadower D, Tarr PI, Gorelick MH, et al. Validation of the modified Vesikari score in children with gastroenteritis in 5 US emergency departments. J Pediatr Gastroenterol Nutr 2013;57:514-9.
15. Freedman SB, Williamson-Urquhart S, Schuh S, et al. Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial. Trials 2014; 15:170.
16. The treatment of diarrhoea: a manual for physicians and other senior health workers. 4th rev. Geneva: World Health Organization, 2005.
17. Muñoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis 2005;40:1625-34.
18. Riquelme AJ, Calvo MA, Guzmán AM, et al. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin Gastroenterol 2003;36:41-3.
19. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:651-9.
20. Freedman SB, Willan AR, Boutis K, Schuh S. Effect of dilute apple juice and preferred fluids vs electrolyte maintenance solution on treatment failure among children with mild gastroenteritis: a randomized clinical trial. JAMA 2016;315: 1966-74.
21. Freedman SB, Xie J, Nettel-Aguirre A, et al. Enteropathogen detection in children with diarrhoea, or vomiting, or both, comparing rectal flocked swabs with stool specimens: an outpatient cohort study. Lancet Gastroenterol Hepatol 2017;2:662-9.
22. Perry MD, Corden SA, Howe RA. Evaluation of the Luminex xTAG Gastrointestinal Pathogen Panel and the Savyon Diagnostics Gastrointestinal Infection Panel for the detection of enteric pathogens in clinical samples. J Med Microbiol 2014;63: 1419-26.
23. Alpern ER, Henretig FM. Fever. In: Fleisher GR, Ludwig S, eds. Textbook of pediatric emergency medicine. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2010:266-75.
24. Binka FN, Anto FK, Oduro AR, et al. Incidence and risk factors of paediatric rotavirus diarrhoea in northern Ghana. Trop Med Int Health 2003;8:840-6.
25. Kim A, Chang JY, Shin S, et al. Epidemiology and factors related to clinical severity of acute gastroenteritis in hospitalized children after the introduction of rotavirus vaccination. J Korean Med Sci 2017;32:465-74.
26. Huppertz HI, Forster J, Heininger U, Roos R, Neumann HU, Hammerschmidt T. The parental appraisal of the morbidity of diarrhea in infants and toddlers (PAMODI) survey. Clin Pediatr (Phila) 2008;47:363-71.
27. Giannattasio A, Guarino A, Lo Vecchio A. Management of children with prolonged diarrhea. F1000Res 2016;5:1-11.
28. Holm S. A simple sequentially rejec-tive multiple test procedure. Scand J Stat 1979;6:65-70.
29. Freedman SB, Powell E, Seshadri R. Predictors of outcomes in pediatric enteritis: a prospective cohort study. Pediatrics 2009;123(1):e9-e16.
30. van Elteren PH. On the combination of independent two sample tests of Wil-coxon. Bull Int Stat Inst 1960;37:351-61.
31. Friedman JN, Goldman RD, Srivas-tava R, Parkin PC. Development of a clinical dehydration scale for use in children between 1 and 36 months of age. J Pediatr 2004;145:201-7.
32. Freedman SB, Vandermeer B, Milne A, Hartling L. Diagnosing clinically significant dehydration in children with acute gastroenteritis using noninvasive methods: a meta-analysis. J Pediatr 2015;166(4): 908-16.e1.
33. Szajewska H, Guarino A, Hojsak I, et al. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for probiotics and prebiotics. J Pediatr Gastroenterol Nutr 2014;58:531-9.
34. King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003;52:(RR-16):1-16.
35. National Institute for Health and Care Excellence. Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management: clinical guidelines CG84. April 2009 (http://www.nice.org.uk/guidance/cg84).
36. Guarino A, Ashkenazi S, Gendrel D, Lo Vecchio A, Shamir R, Szajewska H. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr 2014;59:132-52.
37. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010;11:CD003048.
38. Gonzalez-Ochoa G, Flores-Mendoza LK, Icedo-Garcia R, Gomez-Flores R, Tamez-Guerra P. Modulation of rotavirus severe gastroenteritis by the combination of probiotics and prebiotics. Arch Microbiol 2017;199:953-61.
39. Canani RB, Cirillo P, Terrin G, et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 2007;335:340.
40. Freedman SB, Sherman PM, Willan A, Johnson D, Gouin S, Schuh S. Emergency department treatment of children with diarrhea who attend day care: a randomized multidose trial of a Lactobacillus helveticus and Lactobacillus rhamnosus combination probiotic. Clin Pediatr (Phila) 2015;54:1158-66.
41. Manzano S, De Andrés J, Castro I, Ro-dríguez JM, Jiménez E, Espinosa-Martos I. Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial. Benef Microbes 2017;8:569-78.
42. Foster LM, Tompkins TA, Dahl WJ. A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011. Benef Microbes 2011;2:319-34.
43. Sengül N, Işık S, Aslım B, Uçar G, Demirbağ AE. The effect of exopolysac-charide-producing probiotic strains on gut oxidative damage in experimental colitis. Dig Dis Sci 2011;56:707-14.
44. Sherman PM, Johnson-Henry KC, Yeung HP, Ngo PS, Goulet J, Tompkins TA. Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and entero-pathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun 2005;73:5183-8.
45. Wine E, Gareau MG, Johnson-Henry K, Sherman PM. Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells. FEMS Microbiol Lett 2009;300:146-52.
46. Wallace TD, Bradley S, Buckley ND, Green-Johnson JM. Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production. J Food Prot 2003;66:466-72.
47. Firmesse O, Mogenet A, Bresson JL, Corthier G, Furet JP. Lactobacillus rhamnosus R11 consumed in a food supplement survived human digestive transit without modifying microbiota equilibrium as assessed by real-time polymerase chain reaction. J Mol Microbiol Biotech-nol 2008;14:90-9.
48. Tompkins TA, Barreau G, de Carvalho VG. Draft genome sequence of probiotic strain Lactobacillus rhamnosus R0011. J Bacteriol 2012;194:902.
49. Cordoba G, Schwartz L, Woloshin S, Bae H, Gøtzsche PC. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review. BMJ 2010;341:c3920.
50. Allen SJ, Wareham K, Wang D, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multi-centre trial. Lancet 2013;382:1249-57.
51. Ringel-Kulka T, McRorie J, Ringel Y. Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the benefit of the probiotic bifi-dobacterium infantis 35624 in non-patients with symptoms of abdominal discomfort and bloating. Am J Gastroenterol 2017; 112:145-51.
52. Cabana MD, McKean M, Caughey AB, et al. Early probiotic supplementation for eczema and asthma prevention: a randomized controlled trial. Pediatrics 2017; 140(3):e20163000.
53. Panigrahi P, Parida S, Nanda NC, et al. A randomized synbiotic trial to prevent sepsis among infants in rural India. Nature 2017;548:407-12.
54. Owino V, Ahmed T, Freemark M, et al. Environmental enteric dysfunction and growth failure/stunting in global child health. Pediatrics 2016;138(6):e20160641. Copyright © 2018 Massachusetts Medical Society.